Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The tumor microenvironmentCurrent biology, 2020-08, Vol.30 (16), p.R921-R925 [Peer Reviewed Journal]2020 ;Copyright © 2020. Published by Elsevier Inc. ;ISSN: 0960-9822 ;EISSN: 1879-0445 ;DOI: 10.1016/j.cub.2020.06.081 ;PMID: 32810447Full text available |
|
2 |
Material Type: Article
|
FerroptosisCurrent biology, 2020-11, Vol.30 (21), p.R1292-R1297 [Peer Reviewed Journal]Copyright © 2020 Elsevier Inc. All rights reserved. ;ISSN: 0960-9822 ;EISSN: 1879-0445 ;DOI: 10.1016/j.cub.2020.09.068 ;PMID: 33142092Full text available |
|
3 |
Material Type: Article
|
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline UpdateJournal of clinical oncology, 2020-02, Vol.38 (5), p.496-520 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.01461 ;PMID: 31381464Full text available |
|
4 |
Material Type: Article
|
World Scientists’ Warning of a Climate Emergency 2021BioScience, 2021-09, Vol.71 (9), p.894-898 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the American Institute of Biological Sciences. 2021 ;2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://academic.oup.com/journals/pages/coronavirus . ;The Author(s) 2021. Published by Oxford University Press on behalf of the American Institute of Biological Sciences. ;ISSN: 0006-3568 ;EISSN: 1525-3244 ;DOI: 10.1093/biosci/biab079Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Multiple threats imperil freshwater biodiversity in the AnthropoceneCurrent biology, 2019-10, Vol.29 (19), p.R960-R967 [Peer Reviewed Journal]2019 ;ISSN: 0960-9822 ;EISSN: 1879-0445 ;DOI: 10.1016/j.cub.2019.08.002Full text available |
|
6 |
Material Type: Article
|
NF-κB, inflammation, immunity and cancer: coming of ageNature reviews. Immunology, 2018-05, Vol.18 (5), p.309-324 [Peer Reviewed Journal]ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/nri.2017.142 ;PMID: 29379212Full text available |
|
7 |
Material Type: Article
|
World Scientists’ Warning to Humanity: A Second NoticeBioscience, 2017-12, Vol.67 (12), p.1026-1028 [Peer Reviewed Journal]2017 American Institute of Biological Sciences ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0006-3568 ;ISSN: 1525-3244 ;EISSN: 1525-3244 ;DOI: 10.1093/biosci/bix125Full text available |
|
8 |
Material Type: Article
|
Climate Change, Human Impacts, and Coastal Ecosystems in the AnthropoceneCurrent biology, 2019-10, Vol.29 (19), p.R1021-R1035 [Peer Reviewed Journal]2019 Elsevier Ltd ;ISSN: 0960-9822 ;EISSN: 1879-0445 ;DOI: 10.1016/j.cub.2019.08.042Full text available |
|
9 |
Material Type: Article
|
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid TumorsClinical cancer research, 2019-07, Vol.25 (13), p.3753-3758 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-4070 ;PMID: 30787022Full text available |
|
10 |
Material Type: Article
|
World Scientists’ Warning of a Climate Emergency 2022Bioscience, 2022-11, Vol.72 (12), p.1149-1155 [Peer Reviewed Journal]ISSN: 0006-3568 ;EISSN: 1525-3244 ;DOI: 10.1093/biosci/biac083Full text available |
|
11 |
Material Type: Article
|
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II TrialJournal of clinical oncology, 2018-02, Vol.36 (5), p.446-453 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2017.75.4853 ;PMID: 29240541Full text available |
|
12 |
Material Type: Article
|
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid LeukemiaJournal of clinical oncology, 2018-09, Vol.36 (26), p.2684-2692 [Peer Reviewed Journal]2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.77.6112 ;PMID: 30024784Full text available |
|
13 |
Material Type: Article
|
Planning experiments: Updated guidance on experimental design and analysis and their reporting IIIBritish journal of pharmacology, 2022-08, Vol.179 (15), p.3907-3913 [Peer Reviewed Journal]2022 The British Pharmacological Society. ;2022 The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15868 ;PMID: 35673806Full text available |
|
14 |
Material Type: Article
|
Fundamental Mechanisms of Immune Checkpoint Blockade TherapyCancer discovery, 2018-09, Vol.8 (9), p.1069-10862018 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-18-0367 ;PMID: 30115704Full text available |
|
15 |
Material Type: Article
|
Immunotherapy in Non-Small Cell Lung Cancer: Facts and HopesClinical cancer research, 2019-08, Vol.25 (15), p.4592-4602 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-1538 ;PMID: 30824587Full text available |
|
16 |
Material Type: Article
|
Consensus statement on concussion in sport—the 5th international conference on concussion in sport held in Berlin, October 2016British journal of sports medicine, 2017-06, Vol.51 (11), p.838-847 [Peer Reviewed Journal]Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Copyright: 2017 (c) Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;ISSN: 0306-3674 ;EISSN: 1473-0480 ;DOI: 10.1136/bjsports-2017-097699Full text available |
|
17 |
Material Type: Article
|
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung CancerJournal of clinical oncology, 2018-11, Vol.36 (33), p.JCO2018783118-3297 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.78.3118 ;PMID: 30153097Full text available |
|
18 |
Material Type: Article
|
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 StudyJournal of clinical oncology, 2020-01, Vol.38 (2), p.115-123 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.01488 ;PMID: 31682542Full text available |
|
19 |
Material Type: Article
|
The Critical Role of RNA m6A Methylation in CancerCancer research (Chicago, Ill.), 2019-04, Vol.79 (7), p.1285-1292 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-18-2965Full text available |
|
20 |
Material Type: Article
|
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJournal of clinical oncology, 2018-06, Vol.36 (16), p.1631-1641 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.8671 ;PMID: 29504847Full text available |